179 related articles for article (PubMed ID: 38052256)
21. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R
Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802
[TBL] [Abstract][Full Text] [Related]
22. Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells.
Pawlak A; Henklewska M; Hernández Suárez B; Łużny M; Kozłowska E; Obmińska-Mrukowicz B; Janeczko T
Molecules; 2020 Sep; 25(19):. PubMed ID: 32977440
[TBL] [Abstract][Full Text] [Related]
23. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
24. Novel 3',5'-diprenylated chalcones inhibited the proliferation of cancer cells in vitro by inducing cell apoptosis and arresting cell cycle phase.
Wen Z; Zhang Y; Wang X; Zeng X; Hu Z; Liu Y; Xie Y; Liang G; Zhu J; Luo H; Xu B
Eur J Med Chem; 2017 Jun; 133():227-239. PubMed ID: 28390228
[TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells.
Del Rosario H; Saavedra E; Brouard I; González-Santana D; García C; Spínola-Lasso E; Tabraue C; Quintana J; Estévez F
Bioorg Chem; 2022 Oct; 127():105926. PubMed ID: 35717804
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives.
Burmaoglu S; Aktas Anil D; Gobek A; Kilic D; Yetkin D; Duran N; Algul O
J Biomol Struct Dyn; 2022 May; 40(8):3525-3550. PubMed ID: 33200677
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, in vitro cytotoxicity evaluation and mechanism of 5' monosubstituted chalcone derivatives as antitumor agents.
Xu X; Wang J; Yan B; Leng Y; Chen Z; Pan G; Xiang C; Teng Y
Bioorg Med Chem Lett; 2023 Apr; 85():129239. PubMed ID: 36924947
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents.
Han X; Peng B; Xiao BB; Sheng-Li Cao ; Yang CR; Wang WZ; Wang FC; Li HY; Yuan XL; Shi R; Liao J; Wang H; Li J; Xu X
Eur J Med Chem; 2019 Jan; 162():586-601. PubMed ID: 30472605
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of messagenin and platanic acid chalcone derivatives and their biological potential.
Khusnutdinova E; Galimova Z; Lobov A; Baikova I; Kazakova O; Thu HNT; Tuyen NV; Gatilov Y; Csuk R; Serbian I; Hoenke S
Nat Prod Res; 2022 Oct; 36(20):5189-5198. PubMed ID: 33970717
[TBL] [Abstract][Full Text] [Related]
31. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
33. Anti-proliferative effect of chalcone derivatives through inactivation of NF-κB in human cancer cells.
Venkateswararao E; Sharma VK; Yun J; Kim Y; Jung SH
Bioorg Med Chem; 2014 Jul; 22(13):3386-92. PubMed ID: 24835787
[TBL] [Abstract][Full Text] [Related]
34. 3-Aminomethyl pyridine chalcone derivatives: Design, synthesis, DNA binding and cytotoxic studies.
Durgapal SD; Soni R; Umar S; Suresh B; Soman SS
Chem Biol Drug Des; 2018 Jul; 92(1):1279-1287. PubMed ID: 29575807
[TBL] [Abstract][Full Text] [Related]
35. Novel indolyl-chalcone derivatives inhibit A549 lung cancer cell growth through activating Nrf-2/HO-1 and inducing apoptosis in vitro and in vivo.
Zhao X; Dong W; Gao Y; Shin DS; Ye Q; Su L; Jiang F; Zhao B; Miao J
Sci Rep; 2017 Jun; 7(1):3919. PubMed ID: 28634389
[TBL] [Abstract][Full Text] [Related]
36. Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study.
Lai W; Chen J; Gao X; Jin X; Chen G; Ye L
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958533
[TBL] [Abstract][Full Text] [Related]
37. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
[TBL] [Abstract][Full Text] [Related]
39. Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity.
Mourad AAE; Mourad MAE; Jones PG
Drug Des Devel Ther; 2020; 14():3111-3130. PubMed ID: 32848361
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of selenophene-based chalcone analogs and assessment of their biological activity as anticancer agents.
Chen YC; Li CW; Chen JJ; Shih TL
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200486. PubMed ID: 36587972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
